Concorde Medicine ApS — Credit Rating and Financial Key Figures

Concorde Medicine ApS (CVR number: 44411504) is a company from KØBENHAVN. The company recorded a gross profit of -109.2 kDKK in 2025. The operating profit was -109.2 kDKK, while net earnings were -81.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -123.7 %, which can be considered poor and Return on Equity (ROE) was -138.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -38.4 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Concorde Medicine ApS's liquidity measured by quick ratio was 0.5 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.